Author:
Monteiro Leonardo L.,Witjes J. Alfred,Agarwal Piyush K.,Anderson Christopher B.,Bivalacqua Trinity J.,Bochner Bernard H.,Boormans Joost L.,Chang Sam S.,Domínguez-Escrig Jose L.,McKiernan James M.,Dinney Colin,Godoy Guilherme,Kulkarni Girish S.,Mariappan Paramananthan,O’Donnell Michael A.,Rentsch Cyrill A.,Shah Jay B.,Solsona Eduardo,Svatek Robert S.,van der Heijden Antoine G.,van Valenberg F. Johannes P.,Kassouf Wassim
Publisher
Springer Science and Business Media LLC
Reference55 articles.
1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386.
https://doi.org/10.1002/ijc.29210
2. Ploeg M, Aben KK, Kiemeney LA (2009) The present and future burden of urinary bladder cancer in the world. World J Urol 27(3):289–293.
https://doi.org/10.1007/s00345-009-0383-3
3. Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F (2017) Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol 71(1):96–108.
https://doi.org/10.1016/j.eururo.2016.06.010
4. Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H, Karakiewicz P, Kassouf W, Kiemeney LA, La Vecchia C, Shariat S, Lotan Y (2013) Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 63(2):234–241.
https://doi.org/10.1016/j.eururo.2012.07.033
5. Philips B, Ball C, Sackett D, et al (2009) Oxford Centre for Evidence-based medicine—levels of evidence (March 2009).
http://www.cebm.net/oxford-centre-evidence-based-medicine-levels-evidence-march-2009/
. Accessed 15 June, 2017